Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pilot study aims to help people with psychosis in africa through peer support and community resources

NCT ID NCT06007105

Knowledge-focused Sponsor: London School of Hygiene and Tropical Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This pilot study tested a community-based intervention for people with psychosis in Malawi, Nigeria, Sierra Leone, and Zimbabwe. The program includes peer support from someone who has experienced psychosis, case management, and help with daily activities like finding work or social events. Researchers measured changes in quality of life over four months to see if the approach is feasible and helpful before planning larger studies.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
SUCCEED Community-Based Intervention (peer support, case management, and livelihoods activities)
What this could lead to
If successful, this pilot could pave the way for larger studies that may improve quality of life and social outcomes for people with psychosis in low-resource settings.
What could go wrong
This is a small pilot study, not a full trial, so results are preliminary. The intervention may not work as well in different communities or may not lead to lasting improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

425 people

The number who actually took part.

Started

Sep 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: Participants with lived experience of psychosis must: * Be consenting/assenting adults (age 18+) * Be able to speak one of the main study languages: English, Chichewa, Krio, Shona, Yoruba * Live within the pilot study area * Have a current or past diagnosis of schizophrenia or other primary psychotic disorder, bipolar or depressive disorder with psychotic symptoms, or a maternal mental health or behavioural disorder with psychotic symptoms, as per the World Health Organisation's International Classification of Diseases Version 11 (see full list of eligible diagnoses, below). For participants recruited from within the health care system, diagnosis will be confirmed from health records. For those identified in the community, a research worker will administer the World Health Organisation's Composite International Diagnostic Interview (WHO CIDI) screening tool for psychosis. The following diagnoses are eligible for inclusion: * Schizophrenia (6A20) * Schizoaffective disorder (6A21) * Schizotypal disorder (6A22) * Acute and transient psychotic disorder (6A23) * Delusional disorder (6A24) * Other specified (6A2Y) or unspecified (6A2Z) primary psychotic disorder * Bipolar type I disorder with psychotic symptoms (6A60.1, 6A60.5, 6A60.7, 6A60.A) * Bipolar type II disorder with psychotic symptoms (6A61.3, 6A61.5) * Single episode depressive disorder with psychotic symptoms (6A70.2, 6A70.4) * Recurrent depressive disorder with psychotic symptoms (6A71.2, 6A71.4) * Mental or behavioural disorder associated with pregnancy, childbirth or the puerperium, with psychotic symptoms (6E21) Exclusion Criteria: * People who are currently homeless, for logistical reasons; the SUCCEED intervention relies on PSWs and CSWs being able to regularly contact participants, including for home visits. * People with secondary psychotic syndromes (6E61), as these are considered to be the direct consequences of physical health conditions as opposed to mental health conditions. * People diagnosed with a substance-induced psychotic disorder (6C40.6-6C47.6), as recovery from substance use conditions is a specialist area outside the scope of the SUCCEED intervention under development.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute and transient psychotic disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

delusional disorder paranoid schizophrenia Psychotic Disorders schizoaffective disorder schizophrenia schizotypal personality disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute and transient psychotic disorder Bipolar type I disorder with psychotic symptoms Bipolar type II disorder with psychotic symptoms Delusional disorder Other specified or unspecified primary psychotic disorder Perinatal mental or behavioural disorder with psychotic symptoms Recurrent depressive disorder with psychotic symptoms Schizoaffective disorder Schizophrenia Schizotypal disorder Single episode depressive disorder with psychotic symptoms

Contacts and locations

Locations

  • Kamuzu University of Health Sciences

    Blantyre, Southern Region, 0000, Malawi

  • University of Ibadan

    Ibadan, Oyo State, 0000, Nigeria

  • University of Makeni

    Makeni, Northen Province, 0000, Sierra Leone

  • University of Zimbabwe

    Harare, North East, 0000, Zimbabwe

More trials for these conditions

Other studies related to the condition(s) this trial covers.